Literature DB >> 3976383

Hearing preservation in acoustic neurinoma surgery.

T Palva, H Troupp, T Jauhiainen.   

Abstract

In a series of 120 patients with acoustic neurinoma, hearing preservation at removal of the tumour via the suboccipital approach was attempted in 30 ears. Hearing was preserved in 13 ears (43%), but in two, hearing was lost entirely in 3 to 4 years; thus the success rate was 36%. In 9 of the remaining 11 ears useful speech discrimination was present. Audiological tests showed increased retrocochlear loss after surgery. A surgical team should master the methods of both translabyrinthine and suboccipital surgery in order to choose the best approach for each patient.

Entities:  

Mesh:

Year:  1985        PMID: 3976383     DOI: 10.3109/00016488509119138

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

1.  Auditory findings after stereotactic radiosurgery in acoustic neurinoma.

Authors:  T Yamasoba; H Kurita; K Ito; M Mizuno; M Nakamura; M Sugasawa; K Sugasawa; T Sasaki
Journal:  Skull Base Surg       Date:  1996

2.  Management of the acoustic neuroma in an only hearing ear.

Authors:  M L Pensak; J M Tew; R W Keith; H R Vanloveren
Journal:  Skull Base Surg       Date:  1991

3.  Linear accelerator-based radiosurgery in the management of skull base meningiomas.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Ngan-Ming Tsang; Kuo-Chen Wei; Chen-Kan Tseng; Joseph Tung-Chien Chang; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

4.  Volume growth rate of acoustic neurinomas.

Authors:  E M Laasonen; H Troupp
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

5.  Long-term hearing outcome after retrosigmoid removal of vestibular schwannoma.

Authors:  Akira Nakamizo; Megumu Mori; Daisuke Inoue; Toshiyuki Amano; Masahiro Mizoguchi; Koji Yoshimoto; Tomio Sasaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.